US Patent

US10188637 — Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same

Formulation · Assigned to Hoffmann La Roche Inc · Expires 2037-03-28 · 11y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a granulate formulation of pirfenidone and methods for making it.

USPTO Abstract

The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.

Drugs covered by this patent

Patent Metadata

Patent number: US10188637
Jurisdiction: US
Classification: Formulation
Expires: 2037-03-28
Drug substance claim: No
Drug product claim: Yes
Assignee: Hoffmann La Roche Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.